¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"accelerated rejection"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® rejection ÇÑ±Û °ÅºÎ
¼³¸í   
  ¾î¶² °³Ã¼ÀÇ Á¶Á÷À» ´Ù¸¥ °³Ã¼¿¡ À̽ÄÇßÀ» ¶§ ±×°ÍÀ» ¹èÁ¦Çϴ »ýü¹ÝÀÀ. °³Ã¼°£¿¡ À̽ļö¼úÀ» Çϸé Ã³À½ 7~10ÀÏ Á¤µµ´Â Ç÷¾×°ø±Þµµ È¸º¹µÇ°í º°´Ù¸¥ ÀÌ»óÀ» ¹ß°ßÇÏÁö ¸øÇÏÁö¸¸, ±× ÈÄ¿¡ ±«»ç°¡ »ý±ä´Ù. ±× ¶§¹®¿¡ Àå±âÀ̽ĠÈÄ¿¡ °¢Á¾ Áõ»óÀÌ ¹ß»ýÇÏ¿© À̽ļö¼úÀÌ ½ÇÆÐ·Î µ¹¾Æ°¡±â ½±´Ù. »ç¶÷ÀǠü³»¿¡ ÀÌÁ¾ÀÇ Á¶Á÷ÀÌ µé¾î°¡¸é ±×¿¡ ´ëÇØ Ç×ü°¡ ¸¸µé¾îÁø´Ù. À̴ Ç÷¾× ¼ÓÀÇ ¸²ÇÁ±¸°¡ ±× ÀÌÁ¾Á¶Á÷¿¡ Á¢ÃËÇÏ¿© È°¼ºÈ­µÈ »óÅ¿¡¼­ ¸²ÇÁÀý·Î µÇµ¹¾Æ¿Í¼­ °Å±â¼­ Ç×ü¸¦ ¸¸µå´Â °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ´Ù. ÀÌ Ç×ü´Â ¼¼Æ÷¼ºÇ×ü¿Í Ã¼¾×¼ºÇ×ü·Î ³ª´©¾îÁö¸ç ÀÌ ¾çÀÚÀÇ °øµ¿ÀÛ¿ë¿¡ ÀÇÇØ °ÅºÎ¹ÝÀÀÀÌ »ý±â´Â °ÍÀ¸·Î º¸ÀδÙ. À̴ °³Ã¼¹æÀ§¹ÝÀÀÀ̶ó°íµµ ÇÒ ¼ö ÀÖÁö¸¸ À̽ÄÁ¶Á÷ÀÇ Ç÷°üÀº ±×°ÍµéÀÇ ÀÛ¿ëÀ¸·Î ³»ÇǼ¼Æ÷°¡ »óÇÏ¿© Ç÷ÀüÀ» Çü¼ºÇϹǷΠÇ÷ÇàÀÌ µÎÀýµÈ´Ù. ±× ¶§¹®¿¡ ±«»ç°¡ »ý±â°í ±«»çÁ¶Á÷Àº Ã¼¿Ü·Î ¹èÃâµÈ´Ù. °ÅºÎ¹ÝÀÀÀº À̽ÄÁ÷ÈÄ¿¡ »ý±â´Â °Í, ¼öÁÖ¿¡¼­ ¼ö°³¿ù ÈÄ¿¡ ºñ±³Àû ±Þ¼ºÀ¸·Î »ý±â´Â °Í, ¼ö³â ÈÄ¿¡ ¼­¼­È÷ »ý±â´Â °ÍÀÌ ÀÖ´Ù. Àå±â À̽Ľÿ¡´Â ÀÌ ¹ÝÀÀÀ» ¾ïÁ¦Çϱâ À§ÇØ ¸é¿ª¾ïÁ¦Á¦³ª ºÎ½Å°ÑÁúÈ£¸£¸óÀ» Åõ¿©ÇÑ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hyperfractionation
    °¡¼Ó°úºÐÇÒ
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯¸®µë, °¡¼Ó½É½Ç°íÀ¯À²µ¿
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • continuous hyperfractionated accelerated radiotherapy
    ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • allograft rejection
    µ¿Á¾À̽İźιÝÀÀ
  • cardiac rejection
    ½ÉÀåÀ̽İźιÝÀÀ
  • first-set rejection
    ÀÏÂ÷°ÅºÎ¹ÝÀÀ
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ¹ÝÀÀ
  • homograft rejection
    µ¿Á¾À̽İźιÝÀÀ
  • rejection
    1. °ÅºÎ, °ÅºÎ¹ÝÀÀ 2. °ÅÀý 3. Æó±â
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
  • specimen rejection
    °Ëü°ÅÀý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rejection
    °ÅºÎ
  • allograft rejection
    µ¿Á¾À̽İźÎ
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated hyperfractionation
    °¡¼Ó°ú´ÙºÐÇÒÁ¶»ç
  • accelerated hypertension
    °¡¼Ó°íÇ÷¾Ð
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯¸®µë
  • continuous hyperfractionated accelerated radiotherapy
    ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • allograft rejection
    µ¿Á¾À̽İźÎ
  • cardiac rejection
    ½ÉÀåÀ̽İźιÝÀÀ
  • first-set rejection
    ÀÏÂ÷°ÅºÎ
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ
  • rejection
    °ÅºÎ
  • rejection reaction
    °ÅºÎ¹ÝÀÀ
  • specimen rejection
    °Ëü°ÅÀý
  • transplant rejection
    À̽İźÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accelerated fractionation
    °¡¼ÓºÐÇÒÁ¶»ç
  • accelerated hyperfractionation
    °¡¼Ó°úºÐÇÒÁ¶»ç
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯À²µ¿.
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ).
  • graft rejection, white
    ¹é»öÈ­ ÀÌ½ÄÆí°ÅºÎ (Ãʱ޼º)
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ)(¡­°ÅºÎ¹ÝÀÀ).
  • homograft rejection
    µ¿Á¾ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ)(¡­ËÞÜúÚãëë).
  • immunologic rejection
    ¸é¿ªÇÐÀû °ÅºÎ.
  • immunological rejection
    ¸é¿ªÇÐÀû°ÅºÎ
  • rejection
    °ÅºÎ (ËÞÜú)
  • rejection phenomenon
    °ÅÀýÇö»ó(ËÞï¾úÞßÚ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accelerated fractionation
    °¡¼ÓºÐÇÒÁ¶»ç
  • accelerated hyperfractionation
    °¡¼Ó°úºÐÇÒÁ¶»ç
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð.
  • accelerated idioventricular rhythm
    °¡¼Ó½É½Ç°íÀ¯À²µ¿.
  • accelerated repopulation
    °¡¼ÓÀçÁõ½Ä
  • accelerated treatment
    °¡¼ÓÄ¡·á
  • continuous hyperfractionated accelerated radiother
    apy (CHART) ¿¬¼Ó°úºÐÇÒ°¡¼Ó¹æ»ç¼±Ä¡·á
  • allograft rejection
    µ¿Á¾À̽İźιÝÀÀ
  • allograft rejection
    µ¿Á¾À̽Ä[Æí]°ÅºÎ[¹ÝÀÀ]
  • allograft rejection =homograft r.
    µ¿Á¾À̽Ä(Æí) °ÅºÎ(¹ÝÀÀ).
  • first set rejection
    1Â÷°ÅºÎ(¹ÝÀÀ).
  • first set rejection
    ÀÏÂ÷°ÅºÎ(¹ÝÀÀ).
  • graft rejection
    ÀÌ½ÄÆí°ÅºÎ(¹ÝÀÀ).
  • graft rejection, white
    ¹é»öÈ­ ÀÌ½ÄÆí°ÅºÎ (Ãʱ޼º)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological rejection
    ¸é¿ª °ÅºÎ(Øóæ¹ËÞÜú)
  • trnsplant rejection
    À̽ÄÁ¶Á÷ °ÅºÎ(ì¹ãÕðÚòÄËÞÜú)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • rejection
    °ÅÀý, °ÅºÎ, ±â°¢
  • transplant rejection
    À̽İźÎ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AR absolute risk; accounts receivable; achievement ratio; actinic reticuloid [syndrome]; active resista...
CMR cardiomodulorespirography; cerebral metabolic rate; chief medical resident; common medical record; c...
CMRR common mode rejection ratio
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AIVR Accelerated Idioventricular rhythm
AF Accelerated fractionation
ASE Accelerated solvent extraction
AR Acute Rejection
ACR Acute cellular rejection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • accelerated death phase
    °¡¼Ó »ç¸ê±â
  • accelerated hypertension
    °¡¼Ó¼º °íÇ÷¾Ð
  • accelerated reaction
    ÃËÁø ¹ÝÀÀ, °¡¼Ó ¹ÝÀÀ
    º¸Åë ¶§º¸´Ù ´Ü ½Ã°£ ³»¿¡ ÀϾ´Â ¹ÝÀÀ.
  • acute rejection vasculitis
    ±Þ¼º °ÅºÎ Ç÷°ü¿°
    ÀÌ½Ä ÈÄ ¸î °³¿ù ³»¿¡ ³ªÅ¸³ª°Å³ª ¸é¿ª¾ïÁ¦¿ä¹ýÀ» Áß´ÜÇßÀ» ¶§ ¹ß»ýÇÒ ¼ö ÀÖ´Ù. ÀÌ·¯ÇÑ È¯ÀÚ´Â ÀÌ½Ä Àå±âÀÇ ±â´ÉÀå¾Ö°¡ ÀÌ½Ä ¼ö¼ú ÈÄ °©Àڱ⠳ªÅ¸³ª¼­ Áö¼Ó¼ºÀ» º¸ÀÌ¸ç °í´ÜÀ§ÀÇ ¸é¿ª¾ïÁ¦¿ä¹ý¿¡ ÀÇÇØ¼­µµ Àß Ä¡À¯µÇÁö ¾Ê´Â´Ù.
  • allogenic rejection
    µ¿Á¾ ÀÌ½Ä °ÅºÎ
    µ¿Á¾ ÀÌ½ÄÆíÀÌ »ýÂøÇÏ´Â ÀÏÀÌ ¾øÀÌ °ÅºÎ´çÇØ¹ö¸®´Â °Í. ÀÌ½ÄÆí°ú °³Ã¼ »çÀÌÀÇ Á¶Á÷ ÀûÇÕ¼º Ç׿øÀÌ ´Ù¸£¸é À̵éÀÇ Ç׿ø¿¡ ´ëÇÑ ¼÷ÁÖÀÇ ¸é¿ª¹ÝÀÀÀÌ ¹æ¾Æ¼è°¡ µÇ¾î ÀÌ½ÄÆíÀÇ ÆÄ±«, Áï ÀÌ½Ä °ÅºÎÀÇ Çö»óÀÌ ¹ß»ýÇÑ´Ù. °ÅºÎÀÇ ÁÖ¿ªÀ» ÇØ³»´Â °ÍÀº ¼¼Æ÷¼º ¸é¿ªÀ̶ó°í ÇÑ´Ù.
  • complete rejection
    ÀüÀûÀÎ °ÅºÎ
  • first set rejection
    ÀÏÂ÷ °ÅºÎ, ÀÏÂ÷ °ÅºÎ ¹ÝÀÀ
    Á¦ 1ȸ°ÀÇ µ¿Á¾ À̽Ŀ¡ ÀϾ´Â °ÅºÎ ¹ÝÀÀÀÇ ¾ç½ÄÀÌ¸ç ºÎÀûÇÕÀÇ Á¤µµ¿¡ µû¶ó 1-3ÁÖ°£ÀÇ Àẹ±â¸¦ °ÅÃÄ ÀÌ½Ä ÆíÀº Å»¶ôÇÑ´Ù. ÀÌ½Ä °ÅºÎ ¹ÝÀÀµµ ºñÀÚ±âÀÇ Ç׿ø¼ºÀ» °¡Áø ¼¼Æ÷¸¦ Á¦°ÅÇϱâ À§ÇÑ ¸é¿ª ¹ÝÀÀÀÌ´Ù.
  • homograft rejection
    µ¿Á¾ ÀÌ½ÄÆí °ÅºÎ ¹ÝÀÀ
    µ¿ÀÏÇÑ Á¾ ³»¿¡¼­ÀÇ À̽Ŀ¡ ´ëÇÑ °ÅºÎ ¹ÝÀÀ.
  • immunologic rejection
    ¸é¿ªÇÐÀû °ÅºÎ
  • proximal tubular rejection
    ÀÎÁ¢ µµ°ü ºÀ¼â
  • rejection
    °ÅÀý, °ÅºÎ, ±â°¢, °ÅºÎ ¹ÝÀÀ
    ÀÌ½Ä Á¶Á÷¿¡ ´ëÇÑ ¸é¿ª ¹ÝÀÀ. °úÀ× ¿¹¹Î¼º °ÅºÎ·Î ±âÁ¸ÀÇ Ç×ü¿¡ ÀÇÇÏ¿© ÀÌ½ÄÆí¿¡ ´ëÇÑ Áï½Ã ÀÀ´ä ¹ÝÀÀÀÌ ÀϾ ¼¶À¯¼Ò Ä§Âø, Ç÷¼ÒÆÇ ÀÀÁý, È£Áß±¸ ħÀ±ÀÌ ÀϾ¸ç °á±¹Àº À̽ÄÀÇ ½ÇÆÐ·Î ³¡³­´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
accelerated rejection A transplant rejection manifested in less than three days.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
accelerated conduction Any pathologically increased speed of conduction; usually occurs between the atrium and ventricles as in the Wolff-Parkinson-White and Lown-Ganong-Levine syndromes; such accelerated pathways provide the bases for particular forms of reentry tachycardia.
(05 Mar 2000)
accelerated hypertension <cardiology> A severe form of acute hypertension that results in the abrupt rise in the blood pressure (diastolic pressure often over 120 mmHg). If left untreated, malignant hypertension can cause damage to the blood vessels in the eye, kidneys, brain and heart. Complications include stroke, heart attack, blindness and renal failure.
Symptoms include headache, blurred vision, nausea, vomiting and lethargy. Neurologic symptoms are also a common finding. Malignant hypertension occurs more commonly in males, African Americans and those with a history for hypertension.
(27 Sep 1997)
accelerated idioventricular rhythm A transient and intermittent type of arrhythmia with episodes lasting from a few seconds to a minute which usually occurs in patients with acute myocardial infarction or with digitalis toxicity. Suppressive therapy is rarely necessary because the ventricular rate is generally less than 100 beats per minute.
(12 Dec 1998)
accelerated phase of leukaemia Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
accelerated reaction A response occurring in a shorter time than expected; the cutaneous manifestations occurring during the period between the second and tenth day following smallpox vaccination; because it is intermediate between a primary reaction and an immediate reaction, it is regarded as evidence of some degree of resistance.
Synonym: vaccinoid reaction.
(05 Mar 2000)
leukaemia, accelerated phase of Refers to chronic myelogenous leukaemia that is progressing. The number of immature, abnormal white blood cells in the bone marrow and blood is higher than in the chronic phase, but not as high as in the blast phase.
(12 Dec 1998)
acute cellular rejection Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage.
See: primary rejection.
Synonym: acute rejection.
(05 Mar 2000)
acute kidney transplant rejection <radiology> Findings on ultrasound: globular enlargment of the kidney, swelling and hypoechogenicity of the medullary pyramids, indistinct cortico-medullary junction, foci in the renal cortex
(12 Dec 1998)
acute rejection Graft rejection which usually begins within 10 days after a graft has been transplanted into a genetically dissimilar host. Lesions at the site of the graft characteristically are infiltrated with large numbers of lymphocytes and macrophages which cause tissue damage.
See: primary rejection.
Synonym: acute rejection.
(05 Mar 2000)
allograft rejection The rejection of tissue transplanted between two genetically different individuals of the same species. Rejection is caused by T lymphocytes responding to the foreign major histocompatibility complex of the graft.
Synonym: homograft.
(05 Mar 2000)
parental rejection Withholding of affection from or denial of attention to one's child.
Child's withholding of affection from its parent.
(05 Mar 2000)
rejection 1. <immunology, surgery> Usually used of grafts. Any process leading to the destruction or detachment of a graft or other specified structure.
2. <psychology> Non-acceptance, negative attitudes, hostility or excessive criticism of the individual which may precipitate feelings of rejection.
(12 Dec 1998)
graft rejection <haematology, immunology> When donated bone marrow infused during a bone marrow transplant is rejected by the patients body or does not take.
(16 Dec 1997)
chronic allograft rejection Immunologically mediated damage to the allograft, typically a kidney allograft, manifested by diffuse interstitial fibrosis glomerular changes, typically membranous and sclerotic in nature, as well as intimal fibrosis of the blood vessels with tubular atrophy and loss of tubular structures.
(05 Mar 2000)
chronic rejection A transplant rejection occurring after a few or many months, mainly from persisting serum antibody action.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • accelerated
    ¼Ó·ÂÀÌ ºÙÀº;°¡¼ÓµÈ
  • rejection
    °ÅÀý
  • rejection
    ¹èÁ¦;Æó±â;°ÅÀý;°¢ÇÏ;ºÎ°á;±¸Åä;Æó±â¹°;°ÅºÎ(°ÅÀý)¹ÝÀÀ
  • rejection front
    °ÅºÎ Àü¼±(À̽º¶ó¿¤°ú ±³¼·.È­ÆòÀ» °ÅºÎÇÏ´Â ¾Æ¶øÁ¦±¹(Á¶Á÷)ÀÇ Àü¼±)
  • rejection slip
    (ÃâÆÇ»ç°¡ äÅà ¾Ê±â·Î ÇÑ ¿ø°í¿¡ ºÙ¿© º¸³»´Â)°ÅÀý ÂÊÁö;°ÅÀýÇ¥
  • rejection stmptom
    °ÅºÎ ¹ÝÀÀ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á